CTVA
Corteva, Inc. NYSE Listed May 24, 2019$79.10
Mkt Cap $53.1B
52w Low $60.53
74.0% of range
52w High $85.63
50d MA $80.62
200d MA $71.86
P/E (TTM)
50.2x
EV/EBITDA
14.1x
P/B
2.2x
Debt/Equity
0.1x
ROE
4.5%
P/FCF
16.0x
RSI (14)
—
ATR (14)
—
Beta
0.68
50d MA
$80.62
200d MA
$71.86
Avg Volume
4.1M
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
9330 Zionsville Road · Indianapolis, IN 46268-0735 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.17 | 1.50 | +28.2% | 83.90 | -2.0% | -2.5% | -3.3% | — | — | — | — |
| Feb 3, 2026 | AMC | 0.22 | 0.22 | -1.3% | 75.04 | -2.6% | +0.1% | -3.5% | +0.2% | +1.4% | +0.8% | — |
| Nov 4, 2025 | AMC | -0.51 | -0.23 | +54.6% | 62.50 | +3.5% | +1.9% | -0.8% | +1.6% | +2.2% | +0.2% | — |
| Aug 6, 2025 | AMC | 1.89 | 2.20 | +16.4% | 71.17 | -0.9% | -0.2% | -0.2% | +2.2% | -2.0% | +1.8% | — |
| May 7, 2025 | AMC | 0.87 | 1.13 | +29.3% | 62.48 | +3.4% | +7.0% | +1.4% | +0.3% | -0.1% | -0.5% | — |
| Feb 5, 2025 | AMC | 0.31 | 0.32 | +2.5% | 63.82 | -0.4% | -2.3% | -0.0% | -0.2% | +1.2% | -1.4% | — |
| Nov 6, 2024 | AMC | -0.30 | -0.49 | -61.7% | 61.74 | -6.1% | -5.0% | -0.5% | +0.3% | -2.4% | +0.9% | — |
| Jul 31, 2024 | AMC | 1.73 | 1.83 | +5.8% | 56.10 | -3.8% | -5.5% | -2.7% | -0.5% | -0.3% | -0.8% | — |
| May 1, 2024 | AMC | 0.82 | 0.89 | +8.1% | 53.91 | +5.7% | +5.7% | +0.3% | -1.4% | +2.1% | -1.2% | — |
| Jan 31, 2024 | AMC | 0.06 | 0.15 | +155.5% | 45.48 | +24.2% | +18.9% | -1.9% | -2.3% | +0.6% | +3.8% | — |
| Nov 8, 2023 | AMC | -0.26 | -0.23 | +11.5% | 48.62 | +2.2% | -8.5% | -2.2% | +4.0% | +2.2% | +1.0% | — |
| Aug 3, 2023 | AMC | 1.58 | 1.60 | +1.3% | 55.69 | -1.1% | +0.6% | -2.6% | -0.7% | -1.5% | -2.2% | — |
| May 3, 2023 | AMC | 0.93 | 1.16 | +24.7% | 60.00 | +0.6% | -5.2% | +2.4% | -1.1% | -0.9% | +0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | RBC Capital | Maintains | Outperform → Outperform | — | $79.63 | $79.40 | -0.3% | +0.2% | -0.5% | -0.6% | +0.5% | +2.1% |
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $80.35 | $80.66 | +0.4% | -1.2% | +0.4% | +0.2% | -0.5% | -0.6% |
| Apr 21 | Wells Fargo | Maintains | Overweight → Overweight | — | $80.29 | $80.57 | +0.3% | +0.1% | -1.2% | +0.4% | +0.2% | -0.5% |
| Apr 9 | UBS | Maintains | Neutral → Neutral | — | $83.96 | $84.04 | +0.1% | -0.5% | +0.3% | -0.4% | -0.7% | -2.0% |
| Mar 31 | Argus | Maintains | Buy → Buy | — | $82.95 | $83.00 | +0.1% | +0.9% | +0.1% | +2.0% | -1.4% | +1.3% |
| Feb 17 | Mizuho | Maintains | Outperform → Outperform | — | $75.03 | $75.19 | +0.2% | +0.7% | +1.4% | +0.6% | -0.9% | +0.2% |
| Feb 5 | RBC Capital | Maintains | Outperform → Outperform | — | $75.12 | $74.41 | -0.9% | -3.5% | +0.2% | +1.4% | +0.8% | +1.5% |
| Feb 5 | JP Morgan | Downgrade | Overweight → Neutral | — | $75.12 | $74.41 | -0.9% | -3.5% | +0.2% | +1.4% | +0.8% | +1.5% |
| Feb 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $75.12 | $74.41 | -0.9% | -3.5% | +0.2% | +1.4% | +0.8% | +1.5% |
| Feb 5 | Citigroup | Maintains | Neutral → Neutral | — | $75.12 | $74.41 | -0.9% | -3.5% | +0.2% | +1.4% | +0.8% | +1.5% |
| Jan 27 | Oppenheimer | Maintains | Outperform → Outperform | — | $72.63 | $72.61 | -0.0% | +0.5% | +0.1% | +1.1% | -1.4% | +0.5% |
| Jan 21 | JP Morgan | Maintains | Overweight → Overweight | — | $68.90 | $70.34 | +2.1% | +3.7% | +0.1% | +0.2% | +1.3% | +0.5% |
| Jan 21 | Citigroup | Maintains | Neutral → Neutral | — | $68.90 | $70.34 | +2.1% | +3.7% | +0.1% | +0.2% | +1.3% | +0.5% |
| Jan 16 | Mizuho | Maintains | Outperform → Outperform | — | $70.50 | $69.49 | -1.4% | -1.2% | -1.1% | +3.7% | +0.1% | +0.2% |
| Dec 18 | Citigroup | Maintains | Neutral → Neutral | — | $66.43 | $66.83 | +0.6% | +0.8% | -1.0% | +1.2% | +0.1% | +0.3% |
| Nov 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $65.56 | $65.54 | -0.0% | +0.2% | +1.2% | -0.4% | -0.3% | -3.2% |
| Oct 30 | UBS | Maintains | Buy → Buy | — | $63.20 | $61.28 | -3.0% | -2.4% | -0.4% | +1.0% | +0.7% | +1.9% |
| Oct 16 | Wells Fargo | Maintains | Overweight → Overweight | — | $61.91 | $62.00 | +0.1% | -1.5% | +0.7% | +0.9% | -0.0% | +1.9% |
| Oct 13 | Argus | Maintains | Buy → Buy | — | $61.83 | $62.27 | +0.7% | +1.4% | +0.0% | -1.2% | -1.5% | +0.7% |
| Oct 8 | Mizuho | Maintains | Outperform → Outperform | — | $65.61 | $65.18 | -0.7% | -3.8% | -0.6% | -1.5% | +1.4% | +0.0% |
| Oct 6 | UBS | Maintains | Buy → Buy | — | $63.37 | $63.52 | +0.2% | +1.5% | +2.0% | -3.8% | -0.6% | -1.5% |
| Oct 3 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $63.49 | $62.50 | -1.6% | -0.2% | +1.5% | +2.0% | -3.8% | -0.6% |
| Oct 2 | Citigroup | Downgrade | Buy → Neutral | — | $61.47 | $61.33 | -0.2% | +3.3% | -0.2% | +1.5% | +2.0% | -3.8% |
| Oct 2 | JP Morgan | Upgrade | Neutral → Overweight | — | $61.47 | $61.33 | -0.2% | +3.3% | -0.2% | +1.5% | +2.0% | -3.8% |
| Aug 13 | Barclays | Upgrade | Equal Weight → Overweight | — | $71.03 | $72.04 | +1.4% | +1.8% | -0.6% | -0.2% | +0.7% | +0.2% |
| Aug 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $71.05 | $71.30 | +0.4% | -0.2% | +2.2% | -2.0% | +1.8% | -0.6% |
| Aug 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $71.05 | $71.30 | +0.4% | -0.2% | +2.2% | -2.0% | +1.8% | -0.6% |
| Aug 7 | UBS | Maintains | Buy → Buy | — | $71.17 | $70.51 | -0.9% | -0.2% | -0.2% | +2.2% | -2.0% | +1.8% |
| Jul 17 | Argus | Maintains | Buy → Buy | — | $72.98 | $73.02 | +0.1% | +0.3% | -0.2% | -0.1% | +1.0% | +0.2% |
| Jul 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $73.11 | $73.37 | +0.4% | -1.4% | +1.2% | +0.3% | -0.2% | -0.1% |
| Jul 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $73.57 | $73.78 | +0.3% | -0.6% | -1.4% | +1.2% | +0.3% | -0.2% |
| Jul 10 | RBC Capital | Maintains | Outperform → Outperform | — | $76.20 | $76.07 | -0.2% | -1.8% | -1.7% | -0.6% | -1.4% | +1.2% |
| Jul 9 | UBS | Maintains | Buy → Buy | — | $76.45 | $76.57 | +0.2% | -0.3% | -1.8% | -1.7% | -0.6% | -1.4% |
| Jul 8 | BMO Capital | Maintains | Outperform → Outperform | — | $76.58 | $76.90 | +0.4% | -0.2% | -0.3% | -1.8% | -1.7% | -0.6% |
| Jul 8 | Citigroup | Maintains | Outperform → Outperform | — | $76.58 | $76.90 | +0.4% | -0.2% | -0.3% | -1.8% | -1.7% | -0.6% |
| Jul 7 | Barclays | Maintains | Equal Weight → Equal Weight | — | $77.12 | $77.08 | -0.1% | -0.7% | -0.2% | -0.3% | -1.8% | -1.7% |
| Jun 26 | Citigroup | Maintains | Buy → Buy | — | $73.24 | $73.96 | +1.0% | +1.4% | +0.1% | +0.2% | +0.8% | +2.5% |
| Jun 23 | Wells Fargo | Maintains | Overweight → Overweight | — | $73.72 | $73.79 | +0.1% | +1.0% | -1.5% | -0.1% | +1.4% | +0.1% |
| Jun 6 | Jefferies | Maintains | Buy → Buy | — | $71.20 | $71.42 | +0.3% | +0.6% | +0.5% | -0.6% | +0.7% | +0.6% |
| May 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $67.90 | $67.43 | -0.7% | -0.5% | +1.0% | +0.5% | +0.3% | +0.5% |
| May 12 | Wells Fargo | Maintains | Overweight → Overweight | — | $67.79 | $69.13 | +2.0% | +0.3% | -0.1% | -0.5% | +1.0% | +0.5% |
| May 9 | Oppenheimer | Maintains | Outperform → Outperform | — | $66.86 | $66.71 | -0.2% | +1.4% | +0.3% | -0.1% | -0.5% | +1.0% |
| May 9 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $66.86 | $66.71 | -0.2% | +1.4% | +0.3% | -0.1% | -0.5% | +1.0% |
| May 9 | Citigroup | Maintains | Buy → Buy | — | $66.86 | $66.71 | -0.2% | +1.4% | +0.3% | -0.1% | -0.5% | +1.0% |
| May 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $66.86 | $66.71 | -0.2% | +1.4% | +0.3% | -0.1% | -0.5% | +1.0% |
| May 8 | UBS | Maintains | Buy → Buy | — | $62.48 | $64.63 | +3.4% | +7.0% | +1.4% | +0.3% | -0.1% | -0.5% |
| Apr 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $59.28 | $59.88 | +1.0% | +1.7% | -1.0% | -0.8% | +0.9% | -1.0% |
| Mar 31 | Argus | Upgrade | Hold → Buy | — | $61.06 | $61.30 | +0.4% | +3.1% | +1.0% | +0.7% | -4.2% | -9.0% |
| Feb 11 | BofA Securities | Maintains | Buy → Buy | — | $62.21 | $62.08 | -0.2% | +1.2% | -1.4% | +1.3% | +1.8% | +0.8% |
| Feb 7 | Oppenheimer | Maintains | Outperform → Outperform | — | $62.36 | $62.50 | +0.2% | -0.0% | -0.2% | +1.2% | -1.4% | +1.3% |
No insider trades available.
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Corteva announced key executive leadership appointments for a planned spinoff structure, signaling management readiness for separation and potential operational independence of two entities.
Apr 14
8-K
Corteva, Inc. -- 8-K Filing
Corteva reported fourth-quarter 2025 results with net sales and continued operating losses, potentially signaling ongoing profitability challenges for the agricultural biotechnology company.
Feb 3
Data updated apr 25, 2026 3:52am
· Source: massive.com